Cero Therapeutics holdings sees 400,456 in stock sales by YK Bioventures - Investing.com
| 49271VAM2 | 68.96 1.93 2.88% |
About 55% of 49271VAM2's investors are presently thinking to get in. The analysis of the overall prospects from investing in KDP 335 15 MAR 51 suggests that some traders are, at the present time, interested. The current market sentiment, together with 49271VAM2's historical and current headlines, can help investors time the market. In addition, many technical investors use KDP 335 15 bond news signals to limit their universe of possible portfolio assets.
49271VAM2 |
Cero Therapeutics holdings sees 400,456 in stock sales by YK Bioventures Investing.com
Read at news.google.com
 |
KDP 335 15 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 49271VAM2 bond to make a market-neutral strategy. Peer analysis of 49271VAM2 could also be used in its relative valuation, which is a method of valuing 49271VAM2 by comparing valuation metrics with similar companies.
Peers
49271VAM2 Related Equities
| RCMT | RCM Technologies | 0.87 | ||||
| FRCOF | Fast Retailing | 0.00 | ||||
| 00108WAF7 | 00108WAF7 | 0.00 | ||||
| TRT | Trio Tech | 1.13 | ||||
| BYDDY | BYD Co | 1.48 | ||||
| RBCAA | Republic Bancorp | 1.74 | ||||
| 90331HPL1 | 90331HPL1 | 2.25 | ||||
| SMLR | Semler Scientific | 9.56 |
Other Information on Investing in 49271VAM2 Bond
49271VAM2 financial ratios help investors to determine whether 49271VAM2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 49271VAM2 with respect to the benefits of owning 49271VAM2 security.